These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15942906)

  • 1. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; Martínez-Borra J; Pérez R; Rodríguez M; Fdez-Morera JL; Fuentes D; Rodríguez-Rodero S; Gonzáez S; López-Larrea C
    J Infect Dis; 2005 Jul; 192(1):162-5. PubMed ID: 15942906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus.
    Paladino N; Flores AC; Marcos CY; Fainboim H; Theiler G; Arruvito L; Williams F; Middleton D; Fainboim L
    Tissue Antigens; 2007 Apr; 69 Suppl 1():109-11. PubMed ID: 17445180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
    Rauch A; Laird R; McKinnon E; Telenti A; Furrer H; Weber R; Smillie D; Gaudieri S;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():237-40. PubMed ID: 17445209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
    Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
    Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma.
    Littera R; Zamboni F; Tondolo V; Fantola G; Chessa L; Orrù N; Sanna M; Valentini D; Cappai L; Mulargia M; Caocci G; Arras M; Floris A; Orrù S; La Nasa G; Carcassi C
    Hum Immunol; 2013 Oct; 74(10):1288-94. PubMed ID: 23756163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
    Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
    Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G
    Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
    Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
    Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
    Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
    Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; Miña-Blanco A; Martínez-Borra J; Fuentes D; Rodríguez M; Pérez R; González S; López-Larrea C
    J Infect Dis; 2004 Mar; 189(6):957-63. PubMed ID: 14999597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; López-Larrea C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():241-2. PubMed ID: 17445210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
    García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
    Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C/KIR genotypes in oral lichen planus patients infected or non-infected with hepatitis C virus.
    Carrozzo M; Elia A; Mereu V; Dametto E; Fasano M; Broccoletti R; Rendine S; Amoroso A
    Oral Dis; 2011 Apr; 17(3):309-13. PubMed ID: 20860769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
    Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.